Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)

Published by: Kalorama Information

Published: Feb. 1, 2008 - 250+ Pages

Table of Contents

• Background
  
• Scope and Methodology
  
• Size and Growth of Market

CHAPTER  TWO: OVERVIEW OF CHF

• Background
  
• Pathophysiology
  
  • Types of Heart Failure
    
  • Left Ventricular (LV) Failure
    
  • Right Ventricular (RV) Failure
    
  • Systolic Dysfunction
    
  • Diastolic Dysfunction
    
  • High Output Failure
    
  • Theories of Congestive Heart Failure
    
  • Hemodynamic Response Theory
    
  • Neurohormonal Response Theory
    
  • Renal Response Theory
    
  • Conditions Leading to Congestive Heart Failure
    
  • Myocardial Infarction
    
  • Hypertension
    
  • Cardiomyopathy
    
  • Atrial Fibrillation
    
  • Other Risk Factor
    
  • Diagnosis of Congestive Heart Failure
    
  • Classification of Congestive Heart Failure Patients
    
  • Epidemiology
    
  • United States
    
  • Europe
    
  • Japan

CHAPTER THREE: DEVICE TREATMENT OF CONGESTIVE HEART FAILURE

• Artificial Pacemaker
  
• Ventricular Assist Devices (VADs)
  
• Total Artificial Hearts (TAHs)
  
• American College of Cardiology Guideline

CHAPTER FOUR: CONGESTIVE HEART FAILURE PATIENT MANAGEMENT

• Guidelines for Management of Chronic Heart Failure
  
• Strategies to Maintain Quality Patient Care and Contain Costs

CHAPTER FIVE: WORLD MARKETS

• United States
  
• Europe
  
• Japan

CHAPTER  SIX: COMPANY PROFILES

• Abbott Laboratories
  
• Abiomed, Inc.
  
• Ambu, USA
  
• Aortech International, plc
  
• Arrow International
  
• Atrium Medical Corporation
  
• ATS Medical, Inc.
  
• Bacchus Vascular, Inc.
  
• Berlin Heart AG
  
• Biophan Technologies, Inc.
  
• Biosensors International
  
• Biotronik, Inc.
  
• Boston Scientific
  
• CardiacAssist, Inc.
  
• Cardiac Science Corporation
  
• Cardiogenesis Corporation
  
• Cordis Corporation/Biologics Delivery Systems
  
• CoreValve, Inc.
  
• CryoCath Technologies, Inc.
  
• Cryocor, Inc.
  
• Datascope
  
• Defibtech, LLC
  
• Deltex Medical
  
• Heartlab
  
• Impulse Dynamics USA, Inc.
  
• MedicalCV, Inc.
  
• Medtronic, Inc.
  
• Orqis Medical Corporation
  
• Sorin SpA
  
• Stereotaxis, Inc.
  
• St. Jude Medical, Inc.
  
• Teleflex Medical
  
• Terumo Heart, Inc.
  
• Thoratec Corporation
  
• Ventracor, Inc.
  
• Volcano Corporation

CHAPTER SEVEN: STRATEGIC CONCLUSIONS

• First Conclusion
  
• Second Conclusion
  
• Implications:
  
• Third Conclusion
  
• Implications:
  
• Fourth Conclusion
  
• Implications:
  
• Fifth Conclusion
  
• Implications:
  
• Sixth Conclusion
  
• Implications:
  
• Seventh Conclusion
  
• Implications:
  
• Eighth Conclusion
  
• Implications:

APPENDIX A

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Figure 1-1: Incidence of Congestive Heart Failure Cases in the Major World
  
• Healthcare Markets: 2007 - 2017
  
• Figure 1-2: Prevalence of Congestive Heart Failure Cases in the Major World
  
•  Healthcare Markets: 2007 - 2017
  
• Table 1-1: The Estimated Markets for Devices Used to Treat CHF in the Major
  
• World Healthcare Markets by Geographic Segment
  
• Figure 1-3 Trending in the Estimated Markets for Devices Used to Treat CHF in the Major World Healthcare Markets by Geographic Segment
  
• Figure 1-4: Distribution of the Estimated Markets for Devices Used to Treat CHF in the Major World Healthcare Markets by Geographic Segment

CHAPTER  TWO: OVERVIEW OF CHF

• Table 2-1: International Cardiovascular Disease (CVD) Statistics  
  
• Table 2-2: United States CHF Statistics: 2004
  
• Table 2-3: CHF Data Sources
  
• Table 2-4: Common Contributors to Congestive Heart Failure
  
• Figure 2-1: Incidence and Prevalence of Congestive Heart Failure In the World’s
  Major Healthcare Markets: 2007 - 2017  
  
• Figure 2-2: Incidence Rates of Congestive Heart Failure in the Major World
  
• Healthcare Markets: 200l - 2017 (Cases per Million Population)
  
• Figure 2-3: Prevalence Rates of Congestive Heart Failure in the Major World
  
• Healthcare Markets: 2007 - 2017 (Cases per Million Population)
  
• Figure 2-4: Percentage Breakdown of Deaths from Cardiovascular Diseases: 2003  
  
• Table 2-5: Incidence and Prevalence of CHF in the United States:   2007 - 2017   
  
• Figure 2-5: Incidence and Prevalence of CHF in the United States:  
  2007 - 20017   
  
• Figure 2-6: The Distribution of Congestive Heart Failure In the Five Major European Healthcare Markets:  2007
  
• Table 2-6: Incidence and Prevalence of CHF in the Major Healthcare Markets
  of Europe:  2007 - 2017  (Thousands)
  
• Figure 2-7: Incidence and Prevalence of CHF in the Major Healthcare Markets
  of Europe:  2007 - 20017 (Thousands)  
  
• Table 2-7: Incidence and Prevalence of CHF in Japan:  2007 - 2017
  
• Figure 2-8: Incidence and Prevalence of CHF in Japan:  2007 - 20017

CHAPTER THREE: DEVICE TREATMENT OF CONGESTIVE HEART FAILURE

• Table 3-1: Key Implantable Heart Pacing Devices
  
• Table 3-2: Vascular Assist Devices
  
• Table 3-3: Total Artificial Heart Devices
  
• Table 3-4: Facilities Authorized to Performs Total Artificial Heart Implants

CHAPTER FOUR: CONGESTIVE HEART FAILURE PATIENT MANAGEMENT

• Figure 4-1: ACC/AHA Guideline Summary for Recommended Therapy of
   Congestive Heart Failure by Stage of the Disease
  
• Table 4-1: ACC/AHA Staging of Congestive Heart Failure
  
• Table 4-2: 2005 ACC/AHA Guidelines for Evaluation and Therapy for
  Congestive Heart Failure:

CHAPTER FOUR: CONGESTIVE HEART FAILURE MARKETS

• Table 5-1: The Estimated Markets for Devices Used to Treat CHF in the Major
  World Healthcare Markets by Geographic Segment  
  
• Figure 5-1: Trending in the Estimated Markets for Devices Used to Treat CHF in
  the Major World Healthcare Markets by Geographic Segment
  
• Figure 5-2: Distribution of the Estimated Markets for Devices Used  to Treat CHF
  in the Major World Healthcare Markets  by Geographic Segment
  
• Table 5-2: The Estimated Markets for Devices Used to Treat CHF in the Major
  
• World Healthcare Markets by Device Segment 
  
• Figure 5-3: Trending in the Estimated Markets for Devices to Treat CHF in the
  
• Major World Healthcare Markets by Device Segment
  
• Figure 5-4: Distribution of the Estimated Markets for Devices to Treat CHF
  in the Major World Healthcare Markets by Device Segment
  
• Table 5-3: The Estimated Markets for Devices Used to Treat CHF in the
  
• United States Healthcare Market by Device Segment (Pacemakers, ICDs,
  
• LVADs, and TAHs)  
  
• Figure 5-5: Trending in the Estimated Markets for Devices Used to Treat CHF
   in the United States Healthcare Market by Device Segment
  
• Figure 5-6: Distribution of the Estimated Markets for Devices Used to Treat
  
• CHF in the United States Healthcare Market by Device Segment
  
• Table 5-4: The Estimated Markets for Devices Used to Treat CHF in the
  
•  Five Major European Healthcare Markets by Device Segment 
  
• Figure 5-7: Trending the Estimated Markets for Devices Used to Treat  CHF in
  the Five Major European Healthcare Markets by  Device Segment
  
• Figure 5-8: Distribution of the Estimated Markets for Devices Used to Treat CHF
  in the Five Major European Healthcare Markets by Device Segment
  
• Table 5-5: The Estimated Markets for Devices Used to Treat CHF in the Japanese
  
• Healthcare Market by Device Segment 
  
• Figure 5-9: Trending in the Estimated Markets for Devices Used to Treat
  
• CHF in the Japanese Healthcare Market by Device Segment
  
• Figure 5-10: Distribution of the Estimated Markets for Devices Used to Treat CHF in the Japanese Healthcare Market by Device Segment

Abstract

Kalorama Information's Congestive Heart Failure, Major World Markets series looks at markets for CHF treatment in the United States, Europe, Japan and the Rest of the World. Volume II of this series looks at markets for device management of this disease in the following key categories:

• Pacemakers
• Left Ventricular Assistance Devices (LVADs)
• Implantable Cardioverter/Defibrillators (ICDs)
• Artificial Hearts

• US
• Europe
• Japan
• Rest of World

• Abbott Laboratories
• Abiomed, Inc.
• Ambu, USA
• Aortech International, plc
• Arrow International
• Atrium Medical Corporation
• ATS Medical, Inc.
• Bacchus Vascular, Inc.
• Berlin Heart AG
• Biophan Technologies, Inc.
• Biosensors International
• Biotronik, Inc.
• Boston Scientific
• CardiacAssist, Inc.
• Cardiac Science Corporation
• Cardiogenesis Corporation
• Cordis Corporation/Biologics Delivery Systems
• CoreValve, Inc.
• CryoCath Technologies, Inc.
• Cryocor, Inc.
• Datascope
• Defibtech, LLC
• Deltex Medical
• Heartlab
• Impulse Dynamics USA, Inc.
• MedicalCV, Inc.
• Medtronic, Inc.
• Orqis Medical Corporation
• Sorin SpA
• Stereotaxis, Inc.
• St. Jude Medical, Inc.
• Teleflex Medical
• Terumo Heart, Inc.
• Thoratec Corporation
• Ventracor, Inc.
• Volcano Corporation

Product managers, business development executives, marketing executives and planners are among those who will benefit from this resource.

License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.